| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 4 | |||
| NCT07010302 | Rituximab Versus Ravulizumab, Inebilizumab, Satralizumab, and Eculizumab in NMOSD | NMOSD | Not Yet Recruiting |
| Phase 3 | |||
| NCT04432584 | A Study Evaluating the Safety, Pharmacokinetics, and Efficacy of Crovalimab Versus… | Paroxysmal Nocturnal Hemoglobinuria | Active, Not Recruiting |
| NCT04434092 | A Study Evaluating the Efficacy and Safety of Crovalimab Versus Eculizumab in… | Paroxysmal Nocturnal Hemoglobinuria | Active, Not Recruiting |
| NCT05133531 | A Study to Evaluate How Safe Pozelimab + Cemdisiran Combination Therapy is and How Well… | Paroxysmal Nocturnal Hemoglobinuria | Active, Not Recruiting |
| Phase 2 | |||
| NCT05646563 | Study of NM8074 in Adult PNH Patients With Inadequate Response to Soliris | Paroxysmal Nocturnal Hemoglobinuria | Not Yet Recruiting |
| NCT07184840 | Eculizumab For the Acute Attack of Neuromyelitis Optica Spectrum Disorder | Neuromyelitis Optica Spectrum Disorder Attack | Active, Not Recruiting |